Philips Respironics Trilogy Evo Ventilator Recall Identified as Class I

FDA today identified Philips Respironics Trilogy Evo continuous ventilator recall as Class I, over a month after the company initiated the voluntary correction in March.

The ventilators affected by the recall — Trilogy EV300, Trilogy Evo O2, and Trilogy Evo Universal — use a microprocessor-controlled blower to provide pressure support, pressure control, or volume control during breathing support.